Further Distribution Agreement - PIFA Heparin/PF4

Embargoed: 0700hrs, 12 August 2010

Akers Biosciences, Inc.

("ABI" or the "Company")

Major PIFA Heparin/PF4 Contract

Akers Biosciences, Inc. (AIM:AKR), a leading designer and manufacturer of rapid diagnostic screening and testing products, is pleased to announce that the Company's PIFA Heparin/PF4 Rapid Assay has been added to the HealthTrust Purchasing Group (HPG) laboratory distribution contract.

HealthTrust Purchasing Group (HPG) is one of the leading Group Purchasing Organizations, supporting nearly 1,400 not-for-profit and for-profit acute care hospitals, including Hospital Corporation of America (HCA). HCA owns and operates over 160 hospitals and approximately 105 freestanding surgery centers in 20 US States and the United Kingdom. Other HPG members include a number of premier operators of US-based, acute care hospitals including Community Health Systems, Health Management Associates and Lifepoint.

ABI's President and CEO Thomas A. Nicolette commented:

"We were thrilled to get confirmation of HPG's addition of the PIFA Heparin/PF4 Rapid Assay to its laboratory products contract. PIFA's inclusion was spurred by demand from its member hospitals and we have already shipped orders. We have always been impressed with HPG's commitment to quality patient care and expertise in assessing value-oriented clinical products. We are confident that HPG's member hospitals will continue to find PIFA's time- and cost-saving benefits helpful in the clinical assessment of Heparin-Induced Thrombocytopenia."

Enquiries:

Thomas A. Nicolette

President and CEO

Tel. +1 856 848 8698

Ben Simons

M: Communications

Tel. +44 (0)20 7920 2340

Emma Earl

Daniel Stewart & Co.

Tel. +44 (0)20 7776 6550

About Akers Biosciences, Inc.

Akers Biosciences develops, manufactures, and supplies rapid, point of care screening and testing products designed to bring healthcare information both rapidly and directly to the consumer or healthcare provider. The Company has advanced the science of diagnostics while responding to major shifts in healthcare through the development of several proprietary platform technologies. The company's state-of-the-art rapid diagnostic assays can be performed virtually anywhere in minutes when time is of the essence. ABI has aligned with major healthcare companies and high volume medical products distributors to maximize product offerings, and to be a major worldwide competitor in diagnostics. Additional information on the Company and it products can be found at www.akersbiosciences.com.

About HealthTrust

HealthTrust Purchasing Group is a healthcare group purchasing organization. Established in May 1999, HPG's membership has tripled since its inception and the company supports over 1,400 not-for-profit and for-profit acute care hospitals, including HCA, Health Management Associates, Community Health Systems and Lifepoint, as well as over 3,000 ambulatory surgery centers, alternate care sites and physician practices. Annual purchasing volume is more than $14 billion with double-digit annual percentage growth expected. For more information, visit www.healthtrustcorp.com.